The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to ...
Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...
Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...
Kebilidi is a one-time gene therapy administered directly to the brain in patients with AADC deficiency, rare genetic ...
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...
Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...
After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...
Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback